Celanese Corporation announced it signed a purchase and sale agreement with Element Solutions Inc to divest the Company’s Micromax® portfolio of products. The closing is described as being subject to regulatory approval and other closing conditions.
The Company furnished a press release as Exhibit 99.1 and included forward‑looking statements referencing expected timing, future performance, and deleveraging efforts. The disclosure was furnished under Regulation FD and is not deemed filed for liability purposes.
Celanese Corporation announced its intent to close its acetate tow facility in Lanaken, Belgium to streamline production costs across its global network. The company plans to permanently cease manufacturing operations in the second half of 2026, subject to a consultation process with the facility’s works council and union representatives.
Celanese expects total expenses of $70–90 million, including $55–65 million of non-cash accelerated depreciation of fixed assets and $15–25 million of other shutdown cash costs. The company expects cash outflows related to these actions during fiscal years 2026 through 2028. Employee termination costs will be determined following the consultation and disclosed afterward. Actual charges may vary depending on the consultation outcome.
Timothy Go, a director of Celanese Corporation (CE), reported two open-market purchases of Common Stock on 09/08/2025. The Form 4 shows 500 shares bought at $46.33 and 539 shares bought at $46.175, leaving him with 4,415 total shares beneficially owned after the transactions. The filing was signed by an attorney-in-fact on 09/09/2025.
Mark Christopher Murray, reported as an officer (SVP - Acetyls) of Celanese Corporation (CE), acquired 2,017 shares of Celanese common stock on 08/14/2025 at a reported price of $41.83 per share. Following the transaction the filing reports 17,000 shares beneficially owned in a direct ownership form. The Form 4 was signed by an attorney-in-fact on 08/18/2025. No derivative transactions are reported on this filing.
Celanese Corporation (CE) director Scott McDougald reported a non-derivative purchase of 2,000 shares on 08/14/2025 at a price of $40.8935 per share, increasing his direct beneficial ownership to 20,376 shares. The Form 4 was signed by an attorney-in-fact on 08/18/2025. No derivative transactions or additional remarks were reported.
Insider purchase disclosed: Celanese Corporation director Ganesh Moorthy bought 1,000 shares of CE common stock on 08/14/2025 at a reported price of $40.942 per share, increasing his direct holdings to 6,015 shares. The filing also shows an indirect holding of 3,000 shares held by the Ganesh and Hema Moorthy Revocable Living Trust. The Form 4 was signed by an attorney-in-fact on 08/18/2025.
Celanese Corp director Edward G. Galante reported an open-market purchase of 2,400 shares of Celanese common stock. The trade occurred on August 14, 2025 at a reported weighted average price of $41.272 per share, based on multiple transactions between $40.98 and $41.45.
After this purchase, Galante directly beneficially owned 21,377 Celanese shares, according to the filing.
Insider transaction reported by Celanese director Kim K.W. Rucker. The Form 4 records a derivative acquisition dated 08/11/2025: phantom stock units were recorded as acquired (transaction code A). The filing shows numeric values of 9,506.8 and a price figure of $47.42 in the derivative table. The form clarifies that each phantom share represents the right to receive one share of Celanese common stock and that these phantom shares reflect dividend equivalents credited under the company’s 2008 Deferred Compensation Plan.
The phantom shares become payable in common stock following the director’s termination of service, per the plan language included in the filing. The report was signed by an attorney-in-fact on 08/13/2025 and identifies Rucker as a director of Celanese (CE). The form does not provide additional context such as immediate share transfers, sales, or changes to direct holdings apart from the deferred compensation disclosure.
Deborah J. Kissire, a director of Celanese Corporation (CE), reported an acquisition of phantom stock on 08/11/2025 under the companys 2008 Deferred Compensation Plan. Each phantom share represents the right to receive one share of Celanese common stock. The filing lists 5,916.748 underlying shares and shows a referenced price of $47.42. The phantom shares represent dividend equivalents on compensation deferred under the Plan and become payable in common stock following the termination of Kissires service as a director.
The Form 4 was signed by an attorney-in-fact on 08/13/2025. The transaction is coded as an acquisition (A) of phantom stock rather than a sale or open-market trade, and the reporting person is identified as a director of the issuer.
Celanese Corporation director Jay V. Ihlenfeld reported an acquisition of phantom stock units tied to the company’s common shares. The Form 4 shows a transaction dated 08/11/2025 in which 10,227.219 units of phantom stock were acquired, with an associated figure of $47.42 shown in the table. Each phantom stock unit represents the right to receive one share of Celanese common stock.
These phantom units are described as dividend equivalents under the company’s 2008 Deferred Compensation Plan and are payable in shares of common stock as provided by the Plan following the termination of the reporting person’s service as a director. The filing identifies Ihlenfeld as a director and the Form is filed by one reporting person.